US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.01 against a street estimate of -0.02 — a beat of 150.0%.
Analysts rate Repro Med Systems Inc a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $6.25.
| Fund | Stake |
|---|---|
| First Light Asset Management, LLC | 7.34% |
| Topline Capital Management LLC | 7.31% |
| BlackRock Inc | 5.69% |
| Vanguard Capital Management, LLC | 3.94% |
| Geode Capital Management, LLC | 2.44% |
| Simcoe Capital LLC | 1.79% |
| Meros Investment Management, LP | 1.65% |
| Lionhunter Capital Management, LLC | 1.50% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Repro Med Systems Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.